There were 372 press releases posted in the last 24 hours and 440,595 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
CytoDyn Announces FDA Clearance to Proceed with Phase 2 Clinical Trial of Leronlimab (PRO 140) for Treatment of NASH

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image